Boston Scientific Corporation (BSX) Q2 2021 Earnings Results

Boston Scientific Beats on EPS, Stock Up 3.5%

Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 3.5% increase. Investors may view the EPS beat as a sign of the company's resilience and potential for future growth. However, the lack of revenue data and guidance leaves some uncertainty about overall performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.40	N/A	+7.24%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about the company's performance. They emphasized their commitment to innovation and growth.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing efforts to enhance product offerings and market presence.

Boston Scientific Beats on EPS, Stock Up 3.5%

Key numbers

Management commentary

Boston Scientific Corporation

More earnings this week

Boston Scientific Beats on EPS, Stock Up 3.5%

Key numbers

Management commentary